Live Breaking News & Updates on Merrimack Pharmaceuticals Company Profile

Stay updated with breaking news from Merrimack pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Increases Dividend to $15.10 Per Share

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) announced a dividend on Thursday, May 16th, investing.com reports. Shareholders of record on Tuesday, May 21st will be paid a dividend of 15.10 per share by the biopharmaceutical company on Friday, May 17th. This represents a yield of 99.87%. The ex-dividend date is Monday, May 20th. This […] ....

United States , United Kingdom , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals Company Profile , Merrimack Pharmaceuticals Stock Performance , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Get Free Report , Merrimack Pharmaceuticals Daily ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Passes Above 200 Day Moving Average of $12.28

Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Passes Above 200 Day Moving Average of $12.28
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Merrimack Pharmaceuticals Stock , Wells Fargo Company , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Company Profile , Merrimack Pharmaceuticals Inc , Citigroup Inc , News Ratings For Merrimack Pharmaceuticals Daily , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Get Free Report , State Teachers Retirement System , Wells Fargo , Merrimack Pharmaceuticals Daily ,

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Short Interest Update

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Garyl Crocker , Eric Andersen , Merrimack Pharmaceuticals Trading Down , Wells Fargo Company , Kennedy Capital Management , Merrimack Pharmaceuticals Inc , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals Company Profile , Tower Research Capital , Merrimack Pharmaceuticals , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Get Free Report , Director Eric Andersen , State Teachers Retirement System , Capital Management , Research Capital , State Street Corp , Street Corp , Pharmaceuticals Trading Down , Merrimack Pharmaceuticals Daily ,

Gary L. Crocker Buys 2,000 Shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Stock

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) insider Gary L. Crocker purchased 2,000 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was bought at an average cost of $12.52 per share, with a total value of $25,040.00. Following the purchase, the insider now owns 133,105 shares in the […] ....

United States , United Kingdom General , United Kingdom , Garyl Crocker , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Price Performance , Merrimack Pharmaceuticals Company Profile , Geode Capital Management , News Ratings For Merrimack Pharmaceuticals Daily , Blackrock Inc , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Securities Exchange Commission , Get Free Report , Exchange Commission , Avenue Partners , Street Corp , Capital Management , Merrimack Pharmaceuticals Daily , Nasdaq Mack , Insider Trading , Nsider Trades ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Cut to "Sell" at StockNews.com

StockNews.com downgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Merrimack Pharmaceuticals Stock Performance Shares of MACK opened at $12.19 on Friday. The business has a 50-day moving average of $12.51 and a 200 day moving average […] ....

United Kingdom , United States , Merrimack Pharmaceuticals Stock Performance , Boothbay Fund Management , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Institutional Investors Weigh In On Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Company Profile , Get Rating , Avenue Partners , Fund Management , Jane Street Group , Merrimack Pharmaceuticals Daily ,